Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kamonporn Kotemul"'
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 1, Pp 96-107 (2024)
Monoclonal antibodies (mAbs) are an effective drug for targeted immunotherapy in several cancer types. However, so far, no antibody has been successfully developed for certain types of cancer, including T-cell acute lymphoblastic leukemia (T-ALL). T-
Externí odkaz:
https://doaj.org/article/b201e3cf8ac84d599842443462cd7336
Autor:
Witida Laopajon, Nuchjira Takheaw, Kamonporn Kotemul, Supansa Pata, Suradej Hongeng, Watchara Kasinrerk
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 6, Pp 1145-1156 (2023)
Aim: The present study aims to generate chimeric mouse single-chain variable fragment (scFv) and immunoglobulin G1 (IgG1) crystallizable fragment (Fc) antibody against disialoganglioside (GD2) for the treatment of neuroblastoma (NB). The generated sc
Externí odkaz:
https://doaj.org/article/34d65b7957394f8e82d8ec4a81ca6295
Autor:
Nuchjira Takheaw, Kamonporn Kotemul, Ratthakorn Chaiwut, Supansa Pata, Witida Laopajon, Kuntalee Rangnoi, Montarop Yamabhai, Watchara Kasinrerk
Publikováno v:
Antibodies, Vol 13, Iss 2, p 42 (2024)
CD99 was demonstrated to be a potential target for antibody therapy on T-acute lymphoblastic leukemia (T-ALL). The ligation of CD99 by certain monoclonal antibodies (mAbs) induced T-ALL apoptosis. However, the molecular basis contributing to the apop
Externí odkaz:
https://doaj.org/article/f28b626d3ab646eaa1fe330ebef36dbc
Autor:
Kanyaruck J; Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Nuchjira T; Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Biomedical Technology Research Center, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency at the Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Chaochetdhapada P; Laboratory Animal Center, Chiang Mai University, Chiang Mai, Thailand., Witida L; Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Biomedical Technology Research Center, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency at the Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Kamonporn K; Laboratory Animal Center, Chiang Mai University, Chiang Mai, Thailand., Ratthakorn C; Laboratory Animal Center, Chiang Mai University, Chiang Mai, Thailand., Supansa P; Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Biomedical Technology Research Center, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency at the Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand., Watchara K; Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.; Biomedical Technology Research Center, National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency at the Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.
Publikováno v:
Asian Pacific journal of allergy and immunology [Asian Pac J Allergy Immunol] 2024 Jan 06. Date of Electronic Publication: 2024 Jan 06.